Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Products Successfully to the Market - Report from the CAT-DGTI-GSCN Workshop at the DGTI Annual Meeting 2014.

Celis, Patrick; Ferry, Nicolas; Hystad, Marit; Schüßler-Lenz, Martina; Doevendans, Pieter A; Flory, Egbert; Beuneu, Claire; Reischl, Ilona; Salmikangas, Paula

Celis, Patrick; Ferry, Nicolas; Hystad, Marit; Schüßler-Lenz, Martina; Doevendans, Pieter A; Flory, Egbert; Beuneu, Claire; Reischl, Ilona; Salmikangas, Paula.

Afiliação

Celis P; Committee for Advanced Therapies, European Medicines Agency, London, UK ; European Medicines Agency, London, UK.
Ferry N; Committee for Advanced Therapies, European Medicines Agency, London, UK ; Agence nationale de sécurité du médicament et des produits de santé (ANSM), Paris, France.
Hystad M; Committee for Advanced Therapies, European Medicines Agency, London, UK ; Norwegian Medicines Agency, Oslo, Norway.
Schüßler-Lenz M; Committee for Advanced Therapies, European Medicines Agency, London, UK ; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
Doevendans PA; Committee for Advanced Therapies, European Medicines Agency, London, UK ; European Society of Cardiology, University Medical Center Utrecht, Department of Cardiology, Utrecht, the Netherlands.
Flory E; Committee for Advanced Therapies, European Medicines Agency, London, UK ; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
Beuneu C; Committee for Advanced Therapies, European Medicines Agency, London, UK ; Agence Fédérale des Médicaments et des Produits de Santé, Brussels, Belgium.
Reischl I; Committee for Advanced Therapies, European Medicines Agency, London, UK ; BASG/AGES, Vienna, Austria.
Salmikangas P; Committee for Advanced Therapies, European Medicines Agency, London, UK ; Finnish Medicines Agency, Helsinki, Finland.